Your browser doesn't support javascript.
loading
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.
McShane, Lisa M; Cavenagh, Margaret M; Lively, Tracy G; Eberhard, David A; Bigbee, William L; Williams, P Mickey; Mesirov, Jill P; Polley, Mei-Yin C; Kim, Kelly Y; Tricoli, James V; Taylor, Jeremy M G; Shuman, Deborah J; Simon, Richard M; Doroshow, James H; Conley, Barbara A.
Affiliation
  • McShane LM; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Room 5W130, MSC 9735, 9609 Medical Center Drive, Bethesda, MD 20892-9735, USA. mcshanel@ctep.nci.nih.gov.
BMC Med ; 11: 220, 2013 Oct 17.
Article in En | MEDLINE | ID: mdl-24228635
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Genomics Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Ethics Limits: Humans Language: En Journal: BMC Med Journal subject: MEDICINA Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Genomics Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Ethics Limits: Humans Language: En Journal: BMC Med Journal subject: MEDICINA Year: 2013 Document type: Article Affiliation country: Country of publication: